The invention provides compounds represented by the structural formula ( 1 ): wherein R 1 , R 2 , R 3 and R 4 are as defined in the claims. The compounds are inhibitors of nucleases, and are useful in particular in a method of treatment and/or prevention of proliferative diseases, neurodegenerative diseases, and other genomic instability associated diseases.